NCT06870279View on ClinicalTrials.gov

A Clinical Research of CD70-targeted CAR-NKT Cells (CGC738) Therapy in RCC

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

May 25, 2025

Primary Completion Date

August 1, 2026

Study Completion Date

December 31, 2026

Conditions
Advanced Clear Cell Renal Cell Carcinoma
Interventions
DRUG

CGC738

CAR-NKT Cells treatment

All Listed Sponsors
lead

RenJi Hospital

OTHER